Publication | Closed Access

Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy

Radiation TherapyMedicineMyeloid-derived Suppressor CellsCell BiologyConfers Therapeutic AdvantageCancer TreatmentOncologyRadiation OncologyTumor Biology